151 related articles for article (PubMed ID: 10405875)
1. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming.
Berkovitch M; Dolinski G; Tauber T; Aladjem M; Kaplinsky C
Int J Immunopharmacol; 1999 Jun; 21(6):411-5. PubMed ID: 10405875
[TBL] [Abstract][Full Text] [Related]
2. Neutropenia following intravenous immunoglobulin therapy in adult patients with immune thrombocytopenic purpura: A single center experience and literature review.
Oh SB; Shin HJ
Medicine (Baltimore); 2020 Jan; 99(1):e18624. PubMed ID: 31895820
[TBL] [Abstract][Full Text] [Related]
3. Neutropenia following IVIG therapy in pediatric patients with immune-mediated thrombocytopenia.
Niebanck AE; Kwiatkowski JL; Raffini LJ
J Pediatr Hematol Oncol; 2005 Mar; 27(3):145-7. PubMed ID: 15750446
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effect of intravenous immunoglobulin on peripheral blood neutrophil count in patients with idiopathic thrombocytopenic purpura.
Sugita K; Eguchi M
J Pediatr Hematol Oncol; 2005 Jan; 27(1):7-10. PubMed ID: 15654271
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura.
Jayabose S; Mahmoud M; Levendoglu-Tugal O; Sandoval C; Ozkaynak F; Giamelli J; Visintainer P
J Pediatr Hematol Oncol; 1999; 21(6):514-7. PubMed ID: 10598663
[TBL] [Abstract][Full Text] [Related]
6. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
Hedlund-Treutiger I; Henter JI; Elinder G
J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
[TBL] [Abstract][Full Text] [Related]
7. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
Blanchette VS; Kirby MA; Turner C
Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
Blanchette VS; Luke B; Andrew M; Sommerville-Nielsen S; Barnard D; de Veber B; Gent M
J Pediatr; 1993 Dec; 123(6):989-95. PubMed ID: 8229536
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
13. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
14. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
16. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
[TBL] [Abstract][Full Text] [Related]
17. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
Alioglu B; Avci Z; Ozyurek E; Ozbek N
J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
Duru F; Fisgin T; Yarali N; Kara A
Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Danish I.T.P. Study Group.
Rosthøj S; Nielsen S; Pedersen FK
Acta Paediatr; 1996 Aug; 85(8):910-5. PubMed ID: 8863869
[TBL] [Abstract][Full Text] [Related]
20. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura.
Ruggeri M; Castaman G; De Nardi G; Rodeghiero F
Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
